Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis: Efficiency for Alveolar Macrophage Targeting

Pyrazinamide, a highly specific agent against Mycobacterium tuberculosis is used as first-line drug to treat tuberculosis. The current work aims to formulate polymeric nanoparticles based drug delivery system to sustain the release profile and reduce the dosing frequency of pyrazinamide. Further aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Varma, J. N. Ravi, Kumar, T. Santosh, Prasanthi, B., Ratna, J. Vijaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502139/
https://www.ncbi.nlm.nih.gov/pubmed/26180270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502139/
https://www.ncbi.nlm.nih.gov/pubmed/26180270

Ejemplares similares